4//SEC Filing
Talon Therapeutics, Inc. 4
Accession 0001140361-13-028385
CIK 0001140028operating
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 5:50 PM ET
Size
39.6 KB
Accession
0001140361-13-028385
Insider Transaction Report
Form 4
WEATHERMAN ELIZABETH H
Director
Transactions
- Conversion
Common Stock, $0.001 par value ("Common Stock")
2013-07-16$0.74/sh+65,016,890$47,852,431→ 65,016,890 total(indirect: See footnote (1) and (2)) - Conversion
Common Stock
2013-07-16$0.35/sh+49,537,551$17,338,143→ 152,329,944 total(indirect: See footnote (1) and (2)) - Conversion
Common Stock
2013-07-16$0.30/sh+37,775,503$11,332,651→ 102,792.393 total(indirect: See footnote (1) and (2)) - Conversion
Series A-1 Convertible Preferred Stock, $0.001 Par Value
2013-07-16$100.00/sh−360,000$36,000,000→ 0 total(indirect: See footnotes)Exercise: $0.74From: 2010-06-07→ Common Stock (63,037,004 underlying) - Conversion
Series A-3 Preferred Stock
2013-07-16$100.00/sh−27,000$2,700,000→ 0 total(indirect: See footnotes)Exercise: $0.35From: 2012-11-14→ Common Stock (8,189,762 underlying) - Conversion
Series A-3 Preferred Stock
2013-07-16$100.00/sh−54,000$5,400,000→ 0 total(indirect: See footnotes)Exercise: $0.35From: 2013-01-11→ Common Stock (16,149,398 underlying) - Sale
Common Stock
2013-07-16$0.06/sh−152,329,944$9,139,797→ 0 total(indirect: See footnote (1) and (2)) - Conversion
Series A-1 Preferred Stock
2013-07-16$100.00/sh−11,307$1,130,700→ 0 total(indirect: See footnotes)Exercise: $0.74From: 2010-09-10→ Common Stock (1,979,886 underlying) - Conversion
Series A-2 Convertible Preferred Stock, $0.001 Par Value
2013-07-16$100.00/sh−99,000$9,900,000→ 0 total(indirect: See footnotes)Exercise: $0.30From: 2012-01-09→ Common Stock (37,775,503 underlying) - Conversion
Series A-3 Convertible Preferred Stock, $0.001 Par Value
2013-07-16$100.00/sh−27,000$2,700,000→ 0 total(indirect: See footnotes)Exercise: $0.35From: 2012-07-03→ Common Stock (8,460,526 underlying) - Conversion
Series A-3 Preferred Stock
2013-07-16$100.00/sh−54,000$5,400,000→ 0 total(indirect: See footnotes)Exercise: $0.35From: 2012-08-17→ Common Stock (16,737,865 underlying) - Other
Right to Acquire Series A-3 Convertible Preferred Stock
2013-07-16−420,000→ 0 total(indirect: See footnotes)Exercise: $100.00From: 2012-01-09→ Series A-3 Conv. Pref. Stock (420,000 underlying)
Footnotes (5)
- [F1]See Exhibit 99.1, Note 1.
- [F2]See Exhibit 99.1, Note 2.
- [F3]See Exhibit 99.1, Note 3.
- [F4]See Exhibit 99.1, Note 4.
- [F5]See Exhibit 99.1, Note 5.
Documents
Issuer
Talon Therapeutics, Inc.
CIK 0001140028
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001140028
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 5:50 PM ET
- Size
- 39.6 KB